AtriCure, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M |
| Gross profit | $400.8M | $347.5M | $300.4M | $245.9M | $205.9M |
| Operating income | -$9.4M | -$40.0M | -$26.7M | -$42.7M | $55.2M |
| Operating expenses | $410.2M | $387.5M | $327.1M | $288.6M | $150.7M |
| Cost of revenue | $133.7M | $117.8M | $98.9M | $84.4M | $68.5M |
| Cash from operations | $57.3M | $12.2M | $4.5M | -$22.1M | -$13.8M |
| Capital expenditure | $9.1M | $11.5M | $12.0M | $16.9M | $9.8M |
| Free cash flow | $48.3M | $745,000 | -$7.5M | -$39.0M | -$23.5M |
| Impairments | — | — | $0 | $0 | $82.3M |
| Total assets | $654.2M | $609.3M | $613.9M | $585.4M | $615.3M |
| Total liabilities | $162.2M | $148.4M | $147.8M | $128.7M | $131.6M |
Shares outstanding 50.6M · Free float 84.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.